Dogwood Therapeutics DWTX Business Segments — Operating Expenses

Similar metrics at other companies

ALMSSingle Reportable — Operating Expenses

$100.15M-15.8%

IMNMSingle Reportable — Operating Expenses

-$59.33M-24.7%

TBPHSingle Reportable — Operating Expenses

$27.18M-8.9%

SESSingle Reportable — Operating Expenses

$19.08M-31.4%

IOVASingle Reportable — Operating Expenses

$107.98M-12.1%

URGSingle Reportable — Operating Costs And Expenses

$21.58M+63.0%

Questions, answered.

What is Dogwood Therapeutics's business segments — operating expenses?

Dogwood Therapeutics (DWTX) reported business segments — operating expenses of $5.08M in Q1 2026.

How has Dogwood Therapeutics's business segments — operating expenses changed year-over-year?

Dogwood Therapeutics's business segments — operating expenses increased by 14.6% year-over-year, from $4.43M to $5.08M.

What is the long-term trend for Dogwood Therapeutics's business segments — operating expenses?

Over 2 years (2023 to 2025), Dogwood Therapeutics's business segments — operating expenses has grown at a 126.6% compound annual growth rate (CAGR), from $5.45M to $27.97M.

What does business segments — operating expenses mean?

The sum of all costs incurred in the normal course of business operations, including research, development, and administrative functions. This metric provides a comprehensive view of the company's total cash burn rate and operational footprint.